| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.32 | 0.006 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |